Caxton Associates LP Purchases New Stake in Quintiles Transitional Holdings Inc. (Q)

Caxton Associates LP purchased a new stake in Quintiles Transitional Holdings Inc. (NYSE:Q) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 5,900 shares of the medical research company’s stock, valued at approximately $528,000.

Several other large investors have also recently added to or reduced their stakes in the company. ProShare Advisors LLC raised its position in shares of Quintiles Transitional Holdings by 2.5% in the second quarter. ProShare Advisors LLC now owns 2,920 shares of the medical research company’s stock valued at $261,000 after purchasing an additional 71 shares during the period. Oppenheimer & Co. Inc. raised its position in shares of Quintiles Transitional Holdings by 0.7% in the second quarter. Oppenheimer & Co. Inc. now owns 11,315 shares of the medical research company’s stock valued at $1,013,000 after purchasing an additional 84 shares during the period. Bbva Compass Bancshares Inc. raised its position in shares of Quintiles Transitional Holdings by 4.2% in the second quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock valued at $197,000 after purchasing an additional 88 shares during the period. Cutter & CO Brokerage Inc. raised its position in shares of Quintiles Transitional Holdings by 4.2% in the second quarter. Cutter & CO Brokerage Inc. now owns 3,805 shares of the medical research company’s stock valued at $341,000 after purchasing an additional 152 shares during the period. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of Quintiles Transitional Holdings by 4.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 4,484 shares of the medical research company’s stock valued at $401,000 after purchasing an additional 171 shares during the period. 93.21% of the stock is currently owned by institutional investors.

In other Quintiles Transitional Holdings news, Director Dennis B. Ph D. Gillings sold 968,023 shares of the company’s stock in a transaction on Monday, August 28th. The stock was sold at an average price of $97.33, for a total value of $94,217,678.59. Following the transaction, the director now directly owns 9,071,839 shares of the company’s stock, valued at approximately $882,962,089.87. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Kevin C. Knightly sold 19,339 shares of the company’s stock in a transaction on Friday, August 25th. The shares were sold at an average price of $99.51, for a total value of $1,924,423.89. Following the completion of the transaction, the insider now directly owns 40,650 shares in the company, valued at $4,045,081.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,198,382 shares of company stock worth $1,361,834,375. Insiders own 6.40% of the company’s stock.

Quintiles Transitional Holdings Inc. (Q) traded up 0.868% during midday trading on Wednesday, reaching $97.035. 88,793 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $95.61 and a 200 day moving average price of $88.58. Quintiles Transitional Holdings Inc. has a 12 month low of $70.10 and a 12 month high of $99.95. The company has a market cap of $21.01 billion, a P/E ratio of 281.261 and a beta of 0.62.

Quintiles Transitional Holdings (NYSE:Q) last issued its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The firm had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.96 billion. During the same period in the prior year, the firm posted $0.93 EPS. The company’s revenue for the quarter was up 68.7% on a year-over-year basis. On average, equities analysts anticipate that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.

A number of equities analysts have recently commented on the stock. Zacks Investment Research raised shares of Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $107.00 price target on the stock in a research report on Wednesday. Robert W. Baird restated a “hold” rating and issued a $98.00 price objective on shares of Quintiles Transitional Holdings in a research note on Monday. Royal Bank Of Canada began coverage on shares of Quintiles Transitional Holdings in a research note on Tuesday, September 19th. They issued an “outperform” rating and a $116.00 price objective on the stock. KeyCorp restated a “buy” rating and issued a $100.00 price objective on shares of Quintiles Transitional Holdings in a research note on Sunday, September 24th. Finally, Argus raised their price objective on shares of Quintiles Transitional Holdings from $98.00 to $104.00 and gave the stock a “buy” rating in a research note on Monday, September 18th. Ten investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. Quintiles Transitional Holdings currently has an average rating of “Buy” and a consensus price target of $93.61.

COPYRIGHT VIOLATION WARNING: “Caxton Associates LP Purchases New Stake in Quintiles Transitional Holdings Inc. (Q)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://sportsperspectives.com/2017/10/11/caxton-associates-lp-purchases-new-stake-in-quintiles-transitional-holdings-inc-q.html.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply